News
CSPHF
0.321
NaN%
--
Weekly Report: what happened at CSPHF last week (0422-0426)?
Weekly Report · 4d ago
Weekly Report: what happened at CSPHF last week (0415-0419)?
Weekly Report · 04/22 12:04
Weekly Report: what happened at CSPHF last week (0408-0412)?
Weekly Report · 04/15 11:54
Weekly Report: what happened at CSPHF last week (0401-0405)?
Weekly Report · 04/08 12:00
Weekly Report: what happened at CSPHF last week (0325-0329)?
Weekly Report · 04/01 11:57
Weekly Report: what happened at CSPHF last week (0318-0322)?
Weekly Report · 03/25 12:00
Weekly Report: what happened at CSPHF last week (0311-0315)?
Weekly Report · 03/18 11:58
Stock Disconnect Triggers Investor Exodus From CStone Pharma
Seeking Alpha · 03/14 09:50
Weekly Report: what happened at CSPHF last week (0304-0308)?
Weekly Report · 03/11 11:54
Weekly Report: what happened at CSPHF last week (0226-0301)?
Weekly Report · 03/04 11:57
Weekly Report: what happened at CSPHF last week (0219-0223)?
Weekly Report · 02/26 12:15
Weekly Report: what happened at CSPHF last week (0212-0216)?
Weekly Report · 02/19 12:18
Weekly Report: what happened at CSPHF last week (0205-0209)?
Weekly Report · 02/12 12:03
Weekly Report: what happened at CSPHF last week (0129-0202)?
Weekly Report · 02/05 12:16
Weekly Report: what happened at CSPHF last week (0122-0126)?
Weekly Report · 01/29 11:59
Weekly Report: what happened at CSPHF last week (0115-0119)?
Weekly Report · 01/22 12:05
Weekly Report: what happened at CSPHF last week (0108-0112)?
Weekly Report · 01/15 12:00
Weekly Report: what happened at CSPHF last week (0101-0105)?
Weekly Report · 01/08 12:05
Weekly Report: what happened at CSPHF last week (1225-1229)?
Weekly Report · 01/01 11:58
Weekly Report: what happened at CSPHF last week (1218-1222)?
Weekly Report · 12/25/2023 12:14
More
Webull provides a variety of real-time CSPHF stock news. You can receive the latest news about Cstone through multiple platforms. This information may help you make smarter investment decisions.
About CSPHF
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.